ArticleAllergy and asthma proceedings2023

A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending.

Joseph A Bellanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.